Net profit of Shukra Pharmaceuticals rose 544.30% to Rs 20.36 crore in the quarter ended December 2025 as against Rs 3.16 crore during the previous quarter ended December 2024. Sales rose 269.85% to Rs 39.13 crore in the quarter ended December 2025 as against Rs 10.58 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales39.1310.58 270 OPM %69.3137.15 - PBDT27.664.79 477 PBT26.824.09 556 NP20.363.16 544 Powered by Capital Market - Live News

Shukra Pharmaceuticals has revised the meeting of the Board of Directors which was scheduled to be held on 7 February 2026. The meeting will now be held on 4 February 2026.Powered by Capital Market - Live News

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 February 2026.Powered by Capital Market - Live News

Net profit of Shukra Pharmaceuticals rose 340.74% to Rs 2.38 crore in the quarter ended September 2025 as against Rs 0.54 crore during the previous quarter ended September 2024. Sales rose 5.76% to Rs 5.88 crore in the quarter ended September 2025 as against Rs 5.56 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales5.885.56 6 OPM %-6.9712.05 - PBDT1.011.58 -36 PBT0.200.88 -77 NP2.380.54 341 Powered by Capital Market - Live News

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News